Jack Benner is a notable inventor based in South Hamilton, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of recombinant DNA technology. With a total of 3 patents, his work has advanced the understanding and application of restriction endonucleases and methylases.

Latest Patents

Among his latest patents is a method for cloning and expression of Tth111II restriction endonuclease-methylase in E. coli. This invention relates to recombinant DNA that encodes the Tth111II restriction endonuclease-methylase fusion protein (Tth111IIRM), along with the expression and purification of this protein to near homogeneity. Another significant patent is for the cloning and expression of BseRI restriction endonuclease and BseRI methylase in E. coli. This invention focuses on recombinant DNA that encodes both the BseRI restriction endonuclease and M.BseRI, facilitating their expression in host cells.

Career Highlights

Jack Benner is currently associated with New England Biolabs, Inc., a leading company in the field of molecular biology. His work at this organization has allowed him to collaborate with other talented scientists and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Shuang-Yong Xu and Zhenyu Zhu. Their collaborative efforts have further enhanced the research output and innovation at New England Biolabs, Inc.

Conclusion

Jack Benner's contributions to molecular biology through his patents and work at New England Biolabs, Inc. highlight his role as an influential inventor in the field. His innovative methods continue to impact research and applications in biotechnology.